Intense bitterness and aversive sensory attributes remain major barriers in pharmaceutical product development, often leading to poor dosing compliance and compromised health outcomes. At Gustoceutics™, we specialise in overcoming these challenges through advanced pharmaceutical taste assessment and taste-masking strategy development.
Our scientists bring deep expertise in drug formulation acceptability, focusing on how sensory experience directly influences patient adherence and long-term treatment success. To support formulation teams, we use state-of-the-art analytical technologies, including an advanced electronic tongue (E-tongue) platform that delivers precise, reproducible assessments of bitterness, astringency, after-taste and overall sensory profile.
Using this technology, we generate robust datasets, comprehensive statistical analyses, and benchmarking against known bitter active pharmaceutical ingredients (APIs), empowering our clients with objective evidence early in development.
Collaboration sits at the heart of our approach. We work closely with pharmaceutical partners to help them design palatable, patient-acceptable dosage forms for both investigational and licensed medicines. Our expertise spans all populations, with a particular focus on paediatric and geriatric patients, whose unique taste preferences and sensory challenges demand tailored formulation solutions.
Our Services
Let’s Talk
To find out more, please get in touch to discuss how Gustoceutics can support your formulation development journey.
